Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Sale |
2024-12-31 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 5,689,719 10.200% |
-613,498 (-9.73%) |
Filing History |
| 2024-10-08 5:44 pm Unchanged |
2024-09-30 | 13G | Foghorn Therapeutics Inc. FHTX |
Klarman Family Foundation | 2,139,639 3.900% |
0 (Unchanged) |
Filing History |
| 2024-09-20 6:00 pm Purchase |
2024-09-13 | 13G | Foghorn Therapeutics Inc. FHTX |
Flynn James E | 2,935,295 5.310% |
2,935,295 (New Position) |
Filing History |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 6,303,217 11.392% |
3,493,208 (+124.31%) |
Filing History |
| 2024-05-30 4:51 pm Purchase |
2024-05-20 | 13G | Foghorn Therapeutics Inc. FHTX |
BIOTECHNOLOGY VALUE FUND L P | 5,552,341 9.990% |
5,552,341 (New Position) |
Filing History |
| 2024-05-24 5:00 pm Purchase |
2024-05-22 | 13D | Foghorn Therapeutics Inc. FHTX |
Flagship Ventures Fund V, L.P. | 16,303,949 22.900% |
3,629,829 (+28.64%) |
Filing History |
| 2024-02-09 09:03 am Sale |
2024-02-08 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 2,810,009 6.656% |
-307,385 (-9.86%) |
Filing History |
| 2023-02-09 10:59 am Purchase |
2023-02-09 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 3,117,394 7.457% |
632,560 (+25.46%) |
Filing History |
| 2022-02-09 09:20 am Sale |
2022-02-08 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 2,484,834 6.699% |
-95,800 (-3.71%) |
Filing History |
| 2021-12-13 08:16 am Purchase |
2021-12-10 | 13G | Foghorn Therapeutics Inc. FHTX |
LILLY ELI & CO LLY |
4,000,000 9.700% |
4,000,000 (New Position) |
Filing History |
| 2021-04-19 09:11 am Purchase |
2020-12-31 | 13G | Foghorn Therapeutics Inc. FHTX |
KADOCH CIGALL | 3,957,712 11.050% |
3,957,712 (New Position) |
Filing History |
| 2021-02-08 10:21 am Purchase |
2021-02-05 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 2,580,634 7.041% |
2,580,634 (New Position) |
Filing History |
| 2021-02-03 6:27 pm Purchase |
2020-12-31 | 13G | Foghorn Therapeutics Inc. FHTX |
Klarman Family Foundation | 2,139,639 5.970% |
2,139,639 (New Position) |
Filing History |
| 2020-10-29 5:00 pm Purchase |
2020-10-27 | 13D | Foghorn Therapeutics Inc. FHTX |
Flagship Ventures Fund V, L.P. | 12,674,120 35.500% |
12,674,120 (New Position) |
Filing History |